Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
In this article:
Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.
Advertisement
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.